Zhejiang Dayang Biotech Group
China Updated 9 July 2026
Zhejiang Dayang Biotech Group is a contract manufacturer based in China. It appears in 1 regulatory filing across 1 regulator, without an active US DMF or CEP on file. Its most recent recorded inspection, by US FDA, closed on 10 July 2015 as VAI.
1
registered plants
1 with an FDA FEI number
1
filings
across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| China, China | 3009493201 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| BRELA (TZ) | 1 | None |
Comparing suppliers?
Choose your molecules and target markets. Zhejiang Dayang Biotech Group comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 10 July 2015.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability